AGISS NEWS, AGCR. This company is worth a look.
go2net.newsalert.com
AGISS Forms Software Company, Biochemical Computing Incorporated
PR Newswire - August 17, 1998 15:49
OTTAWA, Aug. 17 /PRNewswire/ -- AGISS Corporation (OTC Bulletin Board: AGCR) announces today the formation of Biochemical Computing Incorporated, a wholly owned subsidiary of AGISS Corporation. Biochemical Computing is a software research and development company, focusing on a product that analyzes the toxicological hazards of drugs or chemicals on living organisms.
"Biochemical Computing is an exciting venture for AGISS Corporation," said Robert Sowah, CEO. "The software developed by Biochemical Computing, which is being tested today at beta sites, will substantially cut the time-to-market for drug and chemical companies by reducing the amount of testing required. The software will also reduce the amount of animal testing required by drug and cosmetic companies."
"Drug and chemical testing is a multi-billion dollar industry," says Anicet Blais, President, "and as one of AGISS Corporations core competencies, the Biochemical Computing software is hoping to carve out a niche for itself."
AGISS Software Corporation is a leading provider of automated conversion tools and services to solve the Year 2000 conversion across many different platforms. Its Canadian methodology for correcting the Millennium problem is called REMEDY2000(TM) and is marketed worldwide. AGISS Software focuses on Year 2000 conversion, Euro Conversion, software development and system integration.
The following is a "safe harbor" statement under the private Securities Litigation Reform Act of 1995: "This release may contain forward-looking statements that involve risks and uncertainties which might cause the actual results to differ materially from those projected in any forward-looking statements. Factors, which could affect actual results include the development and introduction of competitive technologies, the overall market demand for conversion services, the presence of technologically-inferior products and services which are priced or promoted to compete with AGISS."
SOURCE AGISS Corporation
/CONTACT: Thomas M. Dean or Michael Block, both of Murdock Capital
Partners Corp., 212-421-2545, for AGISS Corporation/
(AGCR) |
